Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: Comparison of mortality and costs

Pediatric Infectious Disease Journal

Volumn 28, Issue 5, 2009, Pages 433-435

  Moran, Cassandra ^a,b   Grussemeyer, Chelsea A ^a   Spalding, James R ^c   Benjamin, Daniel K ^a,b   Reed, Shelby D ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

Age groups; Candidiasis; Health care costs; Length of stay; Mortality

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CHILD; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; ONSET AGE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STRAIN DIFFERENCE;

EID: 67649537728     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181920ffd     Document Type: Article

References (10)

1. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis. 2006;25:419-425.
2. Zilberberg MD, Shorr AF, Kollef MH. Secular Trends in Candidemia-Related Hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol. 2008;29:978-980.
3. Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37:634-643.
4. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50:243-260.
5. Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41:1232-1239.
6. Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis. 1998;27:781-788.
7. Trick WE, Fridkin SK, Edwards JR, et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis. 2002;35:627-630.
8. Fridkin SK, Kaufman D, Edwards JR, et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics. 2006;117:1680-1687.
9. Smith PB, Morgan J, Benjamin JD, et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J. 2007;26:197-200.
10. Benjamin DK Jr, Ross K, McKinney RE Jr, et al. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics. 2000;106:712-718.